IO Biotech plans to meet with the FDA this fall to discuss the data from the phase 3 trial of Cylembio and determine next ...

According to SDIC Securities, the global AI-driven drug market has more than doubled since 2021, hitting $1.76 billion in ...

ScaleReady awards multiple G-Rex grants to leading investigators at the USC and CHLA: St. Paul, Minnesota Saturday, August 16, 2025, 12:00 Hrs [IST] ScaleReady in collaboration wi ...

Identifying specific biomarkers and clinical characteristics is crucial for predicting a patient's response to both existing and emerging treatments for chronic spontaneous urticaria, thereby moving ...

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Study Overview: Incyte Corporation is conducting a Phase ...

BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

New findings reveal promising efficacy of irpagratinib and atezolizumab in treating advanced hepatocellular carcinoma with ...

Cidara Therapeutics, Inc.'s CD388 shows promise as a superior flu prophylactic. Click for strong trial results, upcoming ...

1. You may have problems with your prostate that aren’t cancer.